Diagnostic evidence cooperatives: bridging the valley of death in diagnostics development
- PMID: 31093559
- PMCID: PMC6460518
- DOI: 10.1186/s41512-018-0030-9
Diagnostic evidence cooperatives: bridging the valley of death in diagnostics development
Abstract
Background: Diagnostic tests' impact on patient outcomes and health processes is potentially large, and proper evaluations before widespread adoption are warranted. Such evaluations are challenged by the fact that tests can have multiple purposes, in different clinical pathways, with different roles.
Body: The National Institute for Health Research (NIHR) established four Diagnostic Evidence Cooperatives (DEC) in 2013, across England. The aim of these DECs was to facilitate the development and evaluation of clinically relevant in vitro diagnostics, by offering methodological expertise and access to real-life settings for evaluations in patients. In this commentary, we discuss our experience over the past 4 years.
Conclusion: The interaction of industry, researchers, and clinicians has proven to be very worthwhile.
Keywords: Diagnosis; Primary care; Research and development.
Conflict of interest statement
Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
-
- Van den Bruel A, Cleemput I, Aertgeerts B, Ramaekers D, Buntinx F. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. J Clin Epidemiol. 2007;60(11):1116–1122. doi: 10.1016/j.jclinepi.2007.03.015. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous